RESPIRATORY SYNCYTIAL VIRUS BRONCHIOLITIS: HIGH INCIDENCE OF HOSPITALIZATION OF INFANTS BORN AT 33-36 VS. >36 WEEKS GESTATIONAL AGE

2017 ◽  
Author(s):  
DAVID GREENBERG
Keyword(s):  
Respiratory Syncytial Virus ◽  
Gestational Age ◽  
Respiratory Syncytial Virus Bronchiolitis ◽  
High Incidence ◽  
Syncytial Virus ◽  
Incidence Of Hospitalization

scholarly journals Palivizumab reimbursement criteria and neonatal RSV hospitalisation: a regional retrospective review

2021 ◽  
Vol 5 (1) ◽  
pp. e000985
Author(s):  
Valeria Belleudi ◽  
Federico Marchetti ◽  
Marco Finocchietti ◽  
Marina Davoli ◽  
Antonio Addis
Keyword(s):  
Respiratory Syncytial Virus ◽  
Gestational Age ◽  
Retrospective Review ◽  
Lower Prevalence ◽  
Different Seasons ◽  
Syncytial Virus

In Italy, reimbursement restrictions regarding palivizumab prophylaxis approved in 2016 have been revoked in 2017, restoring use in infants with Gestational Age (GA) >29 weeks. Respiratory Syncytial Virus (RSV) hospitalisations and prevalence of palivizumab use in infants aged <6 months during five seasons (2014–2019), were considered according to different GA. Although RSV hospitalisations rate showed no significant changes, during different seasons in all GA, lower prevalence of palivizumab use in 2016 (0.8% vs 0.3%), returned to a higher level following the revoke of restrictions. Changes in reimbursement criteria were not associated with neonatal RSV hospitalisations rate but with a significant impact on palivizumab use.

scholarly journals Does azithromycin modify viral load during severe respiratory syncytial virus bronchiolitis?

2015 ◽  
Vol 136 (4) ◽  
pp. 1129-1131 ◽  
Author(s):  
Avraham Beigelman ◽  
Leonard B. Bacharier ◽  
Jack Baty ◽  
Richard Buller ◽  
Sheila Mason ◽  
...  
Keyword(s):  
Viral Load ◽  
Respiratory Syncytial Virus ◽  
Severe Respiratory Syncytial Virus ◽  
Respiratory Syncytial Virus Bronchiolitis ◽  
Syncytial Virus
Sign in / Sign up

Export Citation Format

Share Document